Senior Leadership

Roughan Sheedy

Smart Imaging Strategy to Accelerate Drug Development
Roughan Sheedy 2

Roughan Sheedy

Chief Executive Officer of IAG
Experienced Life Science Executive.
Roughan Sheedy, previously COO at Invicro, brings over 20 years of success in leading and scaling high-performance imaging clinical research and technology companies. Roughan has held senior roles in Finance and Commercial and has a depth of experience of driving global growth and expansion throughout Europe, the US and Asia.
IAG, Image Analysis Group

Our next-gen platform, R&D and service divisions together with funding mechanisms holistically address the broader issues experienced by biopharma with active and often complex clinical trial pipelines by providing an integrated approach to clinical development and strategic planning.

Image Management Platform

Real-time information, patented data analysis methodologies, flexible reporting options for all stakeholders ensure transparency of trial process and the use of the latest scientific innovation in proving efficacy of your novel treatments.

Contact Us
Careers

In addition to specific listed roles, we are always looking for biotech and pharma experts and enthusiasts with entrepreneurial mindset, can-do attitude and solid scientific background.

Events

Christophe Berthoux, MD

Smart Imaging Strategy to Accelerate Drug Development
archimed-christophe-2_3

Christophe Berthoux, MD

Chairman
Biotech and Pharma Drug Development Strategy
Christophe is IAG's Chairman. He spent his 20+ year career within the Clinical Research industry, and brings extensive expertise and knowdledge of this sector. Christophe was CEO of UK based Synexus, a leading global SMO and European CEO of Citoxlab Christophe Berthoux, is a doctor in veterinary medicine and holds an MBA from Purdue University, Indiana (US). Currently, he is an Operating Parter in ArchiMed, independent investment firm specialized in the Healthcare industries and CEO of NAMSA.
IAG, Image Analysis Group

Our next-gen platform, R&D and service divisions together with funding mechanisms holistically address the broader issues experienced by biopharma with active and often complex clinical trial pipelines by providing an integrated approach to clinical development and strategic planning.

Image Management Platform

Real-time information, patented data analysis methodologies, flexible reporting options for all stakeholders ensure transparency of trial process and the use of the latest scientific innovation in proving efficacy of your novel treatments.

Contact Us
Careers

In addition to specific listed roles, we are always looking for biotech and pharma experts and enthusiasts with entrepreneurial mindset, can-do attitude and solid scientific background.

Events

Dr. Olga Kubassova

Smart Imaging Strategy to Accelerate Drug Development
O-Kubassova

Dr. Olga Kubassova

Founder and President
Extensive expertise in identifying innovative approaches to clinical research, disruptive technology platforms and novel therapeutics.
Mathematician with 10+ years expertise in actively managing innovation in life science companies, asset positioning, strategy and capital raising. Dr. Kubassova is a founder of IAG, Image Analysis Group. She led the organization as a CEO until 2024, bringing extensive expertise and domain knowledge in identifying innovative approaches to clinical research, disruptive technology platforms and novel therapeutics. Dr Kubassova is an active researcher, co-author of 120+ publications, books and book chapters. She is an industry recognized expert, scientific adviser and venture partner to several investment funds, biotechnology and pharma companies, to the UK government and EU funding bodies. Additionally, she is a founding member of 'The 2% club' to support women in leadership positions, scholar of the Royal Society of Medicine, Royal Academy of Engineering, alumni of several business leadership programs by Goldman Sachs, Oxford Said Business School, Business School of University of Leeds, alumni of Business Programme by the New York Economic Development (New York Venture Fellows), 4 time winner of the national and international 'Entrepreneur of the Year' award.
IAG, Image Analysis Group

Our next-gen platform, R&D and service divisions together with funding mechanisms holistically address the broader issues experienced by biopharma with active and often complex clinical trial pipelines by providing an integrated approach to clinical development and strategic planning.

Image Management Platform

Real-time information, patented data analysis methodologies, flexible reporting options for all stakeholders ensure transparency of trial process and the use of the latest scientific innovation in proving efficacy of your novel treatments.

Contact Us
Careers

In addition to specific listed roles, we are always looking for biotech and pharma experts and enthusiasts with entrepreneurial mindset, can-do attitude and solid scientific background.

Events

Jon Himoff

Smart Imaging Strategy to Accelerate Drug Development
Himoff

Jon Himoff

Chief Product Officer
Leading Product Design and Engineering organization with P&L ownership and customer focus.
Turning concepts into new tech-driven businesses and growing them rapidly, is what I enjoy working on the most. I went from blank sheets of paper to an idea, to team creation, to early stage funding, to a multi-million $ sale to a US public company. I have also worked with companies that have great assets, but have lacked a fresh, energetic approach which focuses on next generation offerings and reaches more prospective customers faster.
IAG, Image Analysis Group

Our next-gen platform, R&D and service divisions together with funding mechanisms holistically address the broader issues experienced by biopharma with active and often complex clinical trial pipelines by providing an integrated approach to clinical development and strategic planning.

Image Management Platform

Real-time information, patented data analysis methodologies, flexible reporting options for all stakeholders ensure transparency of trial process and the use of the latest scientific innovation in proving efficacy of your novel treatments.

Contact Us
Careers

In addition to specific listed roles, we are always looking for biotech and pharma experts and enthusiasts with entrepreneurial mindset, can-do attitude and solid scientific background.

Events

Michael Clark, PMP

Smart Imaging Strategy to Accelerate Drug Development
MichaelClark

Michael Clark, PMP

Chief Operating Officer
Building Teams and Scalling Capabilities to Deliver Global Scale Imaging Clinical Trials
A Senior Clinical Director with extensive experience in undertaking strategic planning, oversight and execution of clinical programs and leading staff across multiple project areas globally. Skilled in needs assessment, quality assurance, managing programmes, communicating deadlines and completing projects within budget and on-time. Committed to achieving and exceeding targets in a drive to meet business objectives with strong clinical expertise and stakeholder management abilities.
IAG, Image Analysis Group

Our next-gen platform, R&D and service divisions together with funding mechanisms holistically address the broader issues experienced by biopharma with active and often complex clinical trial pipelines by providing an integrated approach to clinical development and strategic planning.

Image Management Platform

Real-time information, patented data analysis methodologies, flexible reporting options for all stakeholders ensure transparency of trial process and the use of the latest scientific innovation in proving efficacy of your novel treatments.

Contact Us
Careers

In addition to specific listed roles, we are always looking for biotech and pharma experts and enthusiasts with entrepreneurial mindset, can-do attitude and solid scientific background.

Events

Dr. Jan Lundberg, MD, PhD

Smart Imaging Strategy to Accelerate Drug Development
Jan Lundberg_TB Alliance Board of Directors

Dr. Jan Lundberg, MD, PhD

Chair of Scientifc Advisory Board
Novel Drug Discovery and Development
Jan joined IAG in 2018 to chair IAG’s distinguished board of in-house scientists, imaging experts and academic collaborators and closely work with biotech and pharma partners. Jan's expertise and many years of experience are in the critical assessment of novel therapeutic agents and strategic positioning to maximize the chances of their success. Dr. Lundberg, a scientist with over 22 years of experience in global pharmaceutical R&D. Until recently he was heading R&D organization for Ely Lilly and previously – global research for AstraZeneca. He was involved with discovery of more than 200 candidate drugs and 22 approved products across multiple therapeutic areas, including immunology, oncology and neurology; he has been instrumental for the use of imaging cross therapeutic area projects including amyloid and tau PET imaging in Alzheimer’s dementia. His career began in Karolinska institutet, where he was a professor of pharmacology and a co-founder of Aerocrine AB.
IAG, Image Analysis Group

Our next-gen platform, R&D and service divisions together with funding mechanisms holistically address the broader issues experienced by biopharma with active and often complex clinical trial pipelines by providing an integrated approach to clinical development and strategic planning.

Image Management Platform

Real-time information, patented data analysis methodologies, flexible reporting options for all stakeholders ensure transparency of trial process and the use of the latest scientific innovation in proving efficacy of your novel treatments.

Contact Us
Careers

In addition to specific listed roles, we are always looking for biotech and pharma experts and enthusiasts with entrepreneurial mindset, can-do attitude and solid scientific background.

Events